Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q2 FY25 results · Jul–Sep 2024
Amrutanjan Health Care reported revenue from operations of ₹109.92 crore (up 10.7% from Q2 FY24) and net profit of ₹11.80 crore (up 72.2% from Q2 FY24) for Q2 FY25 (Jul–Sep 2024), on a standalone basis.
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 109.92 | 99.31 | +10.7% | 83.74 | +31.3% |
| Other income | 4.05 | 3.95 | +2.5% | 4.45 | −9.1% |
| Total income | 113.96 | 103.26 | +10.4% | 88.19 | +29.2% |
| Profit before tax | 15.94 | 9.21 | +73.2% | 6.35 | +151.1% |
| Net profit for the period | 11.80 | 6.85 | +72.2% | 4.62 | +155.6% |
| EPS, basic (₹) | 4.08 | 2.36 | +72.9% | 1.60 | +155.0% |
| Net margin (%) | 10.7 | 6.9 | 5.5 |
Standalone
- Filed with BSE
- 12 Nov 2024, 19:37 IST
- Board meeting
- 12 Nov 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE